AHA Hypertension Scientific Sessions 2023

2023 年 AHA 高血压科学会议

• 批准号: 10754445
• 负责人: ROBERTO Ariel GOMEZ
• 金额: $ 4.5万
• 依托单位: UNIVERSITY OF VIRGINIA
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-08-01 至 2024-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10754445
• 关键词: Adult; Advocacy; American Heart Association; Area; Authorization documentation; Award; Blood Pressure; Boston; Cardiovascular Diseases; Cardiovascular system; Caregivers; Case Study; Cessation of life; Child; Clinical; Clinical Sciences; Collaborations; Data; Development; Discipline; Education; Environment; Event; Expenditure; Faculty; Feedback; Fostering; Functional disorder; Funding; Genetic; Goals; Grant; Heart Diseases; Hypertension; Institution; International; Journals; Kidney; Kidney Diseases; Knowledge; Learning; Manuscripts; Massachusetts; Mission; Morbidity - disease rate; National Heart, Lung, and Blood Institute; Nature; Obesity; Oral; Patient-Focused Outcomes; Peer Review; Personal Communication; Persons; Physiology; Postdoctoral Fellow; Primary Care; Publications; Publishing; Request for Proposals; Research; Research Personnel; Scientist; Seasons; Senior Scientist; Stroke; Students; Time; Travel; United States; Woman; Work; authority; career; clinical practice; design; early-career faculty; graduate student; improved; innovation; interest; lectures; marginalized community; meetings; oral communication; peer; posters; pressure; primary care provider; renal damage; symposium

Project Summary More than fifty percent of adults and children in the United States suffer from high arterial pressure (hypertension). If untreated, hypertension can cause cardiovascular disease, kidney damage, and stroke. The purpose of this application is to request travel funds to support trainees who wish to attend and participate in the Hypertension Scientific Sessions 2023 to be held September 7–10, 2023 in Boston, Massachusetts. Hypertension Scientific Sessions is the preeminent conference on hypertension, and it is organized by two Councils of the American Heart Association: The Council on Hypertension and the Council on Kidney in Cardiovascular Disease. This meeting is considered one of the most important and prestigious meetings focused on hypertension. The conference includes oral and poster presentations selected from abstracts submitted by clinical and basic researchers, followed by discussions facilitated by leading experts in their respective fields. Attendees will have the opportunity to interact closely with experts from around the world involved in cross- disciplinary research in hypertension, cardiac and kidney disease, genetics, stroke, and obesity. This meeting will offer sessions specifically designed to benefit trainees and early career investigators. In addition, the meeting offers Clinical Practice topics focused on applying clinical science and improving patient outcomes for primary care providers. By supporting the travel, education, and development of promising early-career scientists, we hope to expand and diversify the current workforce, thereby ultimately increasing the innovation of hypertension research. The specific aims of 2023 Hypertension Scientific Sessions and this application are: 1) Provide early- career attendees with a forum to present their research and obtain constructive feedback from a knowledgeable international audience of scientists working in the field of hypertension; 2) Encourage trainees to enhance their current knowledge by attending state-of-the-art and cutting-edge symposia and lectures organized by the Planning Committee of the Hypertension Scientific Sessions; 3) Offer trainees an opportunity to network with their peers and senior scientists in the area of hypertension; and 4) To increase the participation of speakers and moderators from Historically Marginalized communities (HMCs). This award will multiply the participation of researchers from HMCs, trainees, and early career scientists, in a welcoming environment devoted to learning the latest advances in the field of hypertension at a time when institutions are still limiting expenditures on travel.

项目摘要 在美国，超过50%的成人和儿童患有高动脉压 （高血压）。如果不及时治疗，高血压会导致心血管疾病、肾损伤和中风。的 本申请的目的是申请旅行资金，以支持希望参加和参加 2023年高血压科学会议将于2023年9月7日至10日在马萨诸塞州波士顿举行。 高血压科学会议是高血压的卓越会议，它是由两个 美国心脏协会理事会：高血压理事会和肾脏理事会 心血管疾病这次会议被认为是最重要和最有声望的会议之一， 关于高血压会议包括从提交的摘要中选出的口头和海报介绍， 临床和基础研究人员，随后由各自领域的领先专家进行讨论。 与会者将有机会与来自世界各地的专家密切互动， 高血压、心脏和肾脏疾病、遗传学、中风和肥胖症的学科研究。本次会议 将提供专门为使受训人员和早期职业调查人员受益而设计的课程。会议还 提供临床实践主题，重点是应用临床科学和改善患者的结果， 护理提供者。通过支持有前途的早期职业科学家的旅行，教育和发展，我们 希望扩大和多样化目前的劳动力，从而最终增加高血压的创新 research. 2023年高血压科学会议和本申请的具体目标是：1）提供早期- 职业与会者与论坛介绍他们的研究，并获得建设性的反馈，从一个知识渊博的 高血压领域的国际科学家观众; 2）鼓励学员提高他们的 通过参加最先进和最先进的研讨会和讲座， 高血压科学会议计划委员会; 3）为学员提供与 他们的同行和高血压领域的资深科学家;和4）增加演讲者的参与 历史边缘化社区（Historically Marginalized Communities，HMCs）这一奖项将成倍增加的参与， 来自HMC的研究人员，学员和早期职业科学家，在一个热情的环境中致力于学习 高血压领域的最新进展，而此时各机构仍在限制旅行支出。